VR device that treats serious mental illness wins FDA breakthrough designation

The FDA designated digital therapeutics company OxfordVR’s GameChange virtual reality mental health platform a breakthrough device.

Advertisement

The company said June 22 that GameChange is the world’s first immersive therapeutic for serious mental illness. It provides automated VR cognitive behavioral therapy and is available only via prescription.

The virtual reality therapy includes immersive scenarios that guide patients through simulations of everyday situations in public. Patients in a recent clinical trial conducted in partnership with Oxford University and the U.K.’s National Health Service reported high satisfaction with the therapy.

At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.

Register to Attend Webinar

Caring for the caregivers: How health systems are building benefits strategies with mental health at the core

Wednesday, August 12
1:00 PM - 2:00 PM CDT

Presenters: Mark DeFee, Lyra HealthDeborah Visconi, Bergen New Bridge Medical CenterSuneel Kumar Parvathareddy, MD, Advocate/Atrium Health Wilkes Medical CenterEric Parmenter, Quantum HealthMary Beth Lardazabal, DO, DFAPA, Allina Health

Advertisement

Next Up in Behavioral Health Technology

Advertisement

Comments are closed.